nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—SLC15A1—Trandolapril—coronary artery disease	0.12	0.176	CbGbCtD
Midodrine—SLC15A1—Perindopril—coronary artery disease	0.11	0.161	CbGbCtD
Midodrine—SLC15A1—Enalapril—coronary artery disease	0.091	0.133	CbGbCtD
Midodrine—SLC15A1—Ramipril—coronary artery disease	0.091	0.133	CbGbCtD
Midodrine—SLC15A1—Lisinopril—coronary artery disease	0.091	0.133	CbGbCtD
Midodrine—SLC15A1—Captopril—coronary artery disease	0.0681	0.0998	CbGbCtD
Midodrine—CYP2D6—Niacin—coronary artery disease	0.0193	0.0282	CbGbCtD
Midodrine—CYP2D6—Timolol—coronary artery disease	0.0179	0.0262	CbGbCtD
Midodrine—CYP2D6—Captopril—coronary artery disease	0.0158	0.0231	CbGbCtD
Midodrine—CYP2D6—Simvastatin—coronary artery disease	0.0152	0.0223	CbGbCtD
Midodrine—CYP2D6—Lovastatin—coronary artery disease	0.0149	0.0218	CbGbCtD
Midodrine—CYP2D6—Pravastatin—coronary artery disease	0.0149	0.0218	CbGbCtD
Midodrine—CYP2D6—Atorvastatin—coronary artery disease	0.0136	0.0199	CbGbCtD
Midodrine—Melatonin—CALR—coronary artery disease	0.00306	0.684	CrCbGaD
Midodrine—Melatonin—MPO—coronary artery disease	0.000601	0.134	CrCbGaD
Midodrine—Melatonin—ESR1—coronary artery disease	0.000451	0.101	CrCbGaD
Midodrine—Melatonin—CYP2C19—coronary artery disease	0.000362	0.0809	CrCbGaD
Midodrine—Insomnia—Captopril—coronary artery disease	0.000184	0.000842	CcSEcCtD
Midodrine—Angiopathy—Lisinopril—coronary artery disease	0.000184	0.000842	CcSEcCtD
Midodrine—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000184	0.000842	CcSEcCtD
Midodrine—Pruritus—Lovastatin—coronary artery disease	0.000183	0.00084	CcSEcCtD
Midodrine—Paraesthesia—Captopril—coronary artery disease	0.000183	0.000836	CcSEcCtD
Midodrine—Asthenia—Ezetimibe—coronary artery disease	0.000182	0.000836	CcSEcCtD
Midodrine—Gastrointestinal pain—Niacin—coronary artery disease	0.000182	0.000834	CcSEcCtD
Midodrine—Chills—Lisinopril—coronary artery disease	0.000182	0.000833	CcSEcCtD
Midodrine—Nausea—Rosuvastatin—coronary artery disease	0.000182	0.000832	CcSEcCtD
Midodrine—Nervous system disorder—Losartan—coronary artery disease	0.000182	0.000832	CcSEcCtD
Midodrine—Dyspnoea—Captopril—coronary artery disease	0.000181	0.00083	CcSEcCtD
Midodrine—Abdominal pain—Valsartan—coronary artery disease	0.000181	0.000829	CcSEcCtD
Midodrine—Somnolence—Captopril—coronary artery disease	0.000181	0.000828	CcSEcCtD
Midodrine—Tachycardia—Losartan—coronary artery disease	0.000181	0.000828	CcSEcCtD
Midodrine—Feeling abnormal—Pravastatin—coronary artery disease	0.000181	0.000827	CcSEcCtD
Midodrine—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000181	0.000827	CcSEcCtD
Midodrine—Abdominal pain—Olmesartan—coronary artery disease	0.00018	0.000825	CcSEcCtD
Midodrine—Pruritus—Ezetimibe—coronary artery disease	0.00018	0.000824	CcSEcCtD
Midodrine—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000179	0.000821	CcSEcCtD
Midodrine—Dyspepsia—Captopril—coronary artery disease	0.000179	0.00082	CcSEcCtD
Midodrine—Pain—Telmisartan—coronary artery disease	0.000179	0.000819	CcSEcCtD
Midodrine—Agitation—Ramipril—coronary artery disease	0.000179	0.000819	CcSEcCtD
Midodrine—Insomnia—Perindopril—coronary artery disease	0.000179	0.000818	CcSEcCtD
Midodrine—Asthenia—Eplerenone—coronary artery disease	0.000179	0.000818	CcSEcCtD
Midodrine—Mental disorder—Lisinopril—coronary artery disease	0.000178	0.000813	CcSEcCtD
Midodrine—Paraesthesia—Perindopril—coronary artery disease	0.000177	0.000812	CcSEcCtD
Midodrine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000176	0.000808	CcSEcCtD
Midodrine—Pruritus—Eplerenone—coronary artery disease	0.000176	0.000806	CcSEcCtD
Midodrine—Dyspnoea—Perindopril—coronary artery disease	0.000176	0.000806	CcSEcCtD
Midodrine—Abdominal pain—Niacin—coronary artery disease	0.000176	0.000806	CcSEcCtD
Midodrine—Dizziness—Fenofibrate—coronary artery disease	0.000176	0.000804	CcSEcCtD
Midodrine—Somnolence—Perindopril—coronary artery disease	0.000176	0.000804	CcSEcCtD
Midodrine—Feeling abnormal—Trandolapril—coronary artery disease	0.000175	0.000803	CcSEcCtD
Midodrine—Feeling abnormal—Enalapril—coronary artery disease	0.000175	0.0008	CcSEcCtD
Midodrine—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000174	0.000797	CcSEcCtD
Midodrine—Asthenia—Simvastatin—coronary artery disease	0.000174	0.000797	CcSEcCtD
Midodrine—Flatulence—Lisinopril—coronary artery disease	0.000174	0.000796	CcSEcCtD
Midodrine—Dyspepsia—Perindopril—coronary artery disease	0.000174	0.000796	CcSEcCtD
Midodrine—Gastrointestinal pain—Enalapril—coronary artery disease	0.000173	0.000794	CcSEcCtD
Midodrine—Abdominal pain—Pravastatin—coronary artery disease	0.000173	0.000794	CcSEcCtD
Midodrine—Tension—Lisinopril—coronary artery disease	0.000173	0.000793	CcSEcCtD
Midodrine—Dizziness—Clopidogrel—coronary artery disease	0.000173	0.00079	CcSEcCtD
Midodrine—Paraesthesia—Furosemide—coronary artery disease	0.000172	0.000789	CcSEcCtD
Midodrine—Feeling abnormal—Telmisartan—coronary artery disease	0.000172	0.000789	CcSEcCtD
Midodrine—Pruritus—Simvastatin—coronary artery disease	0.000172	0.000786	CcSEcCtD
Midodrine—Dizziness—Lovastatin—coronary artery disease	0.000171	0.000785	CcSEcCtD
Midodrine—Nervousness—Lisinopril—coronary artery disease	0.000171	0.000785	CcSEcCtD
Midodrine—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000171	0.000783	CcSEcCtD
Midodrine—Back pain—Lisinopril—coronary artery disease	0.000171	0.000782	CcSEcCtD
Midodrine—Somnolence—Furosemide—coronary artery disease	0.000171	0.000782	CcSEcCtD
Midodrine—Gastrointestinal disorder—Perindopril—coronary artery disease	0.00017	0.000781	CcSEcCtD
Midodrine—Muscle spasms—Lisinopril—coronary artery disease	0.00017	0.000777	CcSEcCtD
Midodrine—Pain—Perindopril—coronary artery disease	0.000169	0.000773	CcSEcCtD
Midodrine—Abdominal pain—Trandolapril—coronary artery disease	0.000168	0.000771	CcSEcCtD
Midodrine—Dizziness—Ezetimibe—coronary artery disease	0.000168	0.00077	CcSEcCtD
Midodrine—Abdominal pain—Enalapril—coronary artery disease	0.000168	0.000768	CcSEcCtD
Midodrine—Feeling abnormal—Captopril—coronary artery disease	0.000168	0.000768	CcSEcCtD
Midodrine—Insomnia—Losartan—coronary artery disease	0.000167	0.000767	CcSEcCtD
Midodrine—Rash—Fenofibrate—coronary artery disease	0.000167	0.000767	CcSEcCtD
Midodrine—Dermatitis—Fenofibrate—coronary artery disease	0.000167	0.000766	CcSEcCtD
Midodrine—Headache—Fenofibrate—coronary artery disease	0.000166	0.000762	CcSEcCtD
Midodrine—Paraesthesia—Losartan—coronary artery disease	0.000166	0.000762	CcSEcCtD
Midodrine—Gastrointestinal pain—Captopril—coronary artery disease	0.000166	0.000762	CcSEcCtD
Midodrine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000166	0.000759	CcSEcCtD
Midodrine—Abdominal pain—Telmisartan—coronary artery disease	0.000165	0.000757	CcSEcCtD
Midodrine—Dyspnoea—Losartan—coronary artery disease	0.000165	0.000756	CcSEcCtD
Midodrine—Anxiety—Ramipril—coronary artery disease	0.000165	0.000756	CcSEcCtD
Midodrine—Somnolence—Losartan—coronary artery disease	0.000165	0.000754	CcSEcCtD
Midodrine—Dizziness—Eplerenone—coronary artery disease	0.000165	0.000754	CcSEcCtD
Midodrine—Rash—Clopidogrel—coronary artery disease	0.000165	0.000754	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000164	0.000753	CcSEcCtD
Midodrine—Dermatitis—Clopidogrel—coronary artery disease	0.000164	0.000753	CcSEcCtD
Midodrine—Asthenia—Valsartan—coronary artery disease	0.000164	0.000752	CcSEcCtD
Midodrine—Hypertension—Timolol—coronary artery disease	0.000164	0.000752	CcSEcCtD
Midodrine—Pain—Furosemide—coronary artery disease	0.000164	0.000752	CcSEcCtD
Midodrine—Asthenia—Olmesartan—coronary artery disease	0.000163	0.000749	CcSEcCtD
Midodrine—Headache—Clopidogrel—coronary artery disease	0.000163	0.000749	CcSEcCtD
Midodrine—Rash—Lovastatin—coronary artery disease	0.000163	0.000749	CcSEcCtD
Midodrine—Dermatitis—Lovastatin—coronary artery disease	0.000163	0.000748	CcSEcCtD
Midodrine—Dyspepsia—Losartan—coronary artery disease	0.000163	0.000747	CcSEcCtD
Midodrine—Feeling abnormal—Perindopril—coronary artery disease	0.000163	0.000745	CcSEcCtD
Midodrine—Headache—Lovastatin—coronary artery disease	0.000162	0.000744	CcSEcCtD
Midodrine—Pruritus—Valsartan—coronary artery disease	0.000162	0.000742	CcSEcCtD
Midodrine—Dry mouth—Ramipril—coronary artery disease	0.000162	0.000742	CcSEcCtD
Midodrine—Gastrointestinal pain—Perindopril—coronary artery disease	0.000161	0.000739	CcSEcCtD
Midodrine—Anxiety—Timolol—coronary artery disease	0.000161	0.000739	CcSEcCtD
Midodrine—Pruritus—Olmesartan—coronary artery disease	0.000161	0.000738	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000161	0.000737	CcSEcCtD
Midodrine—Abdominal pain—Captopril—coronary artery disease	0.000161	0.000736	CcSEcCtD
Midodrine—Dizziness—Simvastatin—coronary artery disease	0.00016	0.000734	CcSEcCtD
Midodrine—Rash—Ezetimibe—coronary artery disease	0.00016	0.000734	CcSEcCtD
Midodrine—Dermatitis—Ezetimibe—coronary artery disease	0.00016	0.000734	CcSEcCtD
Midodrine—Confusional state—Ramipril—coronary artery disease	0.00016	0.000733	CcSEcCtD
Midodrine—Asthenia—Niacin—coronary artery disease	0.00016	0.000732	CcSEcCtD
Midodrine—Headache—Ezetimibe—coronary artery disease	0.000159	0.00073	CcSEcCtD
Midodrine—Dry mouth—Timolol—coronary artery disease	0.000158	0.000725	CcSEcCtD
Midodrine—Pain—Losartan—coronary artery disease	0.000158	0.000725	CcSEcCtD
Midodrine—Feeling abnormal—Furosemide—coronary artery disease	0.000158	0.000724	CcSEcCtD
Midodrine—Nausea—Fenofibrate—coronary artery disease	0.000158	0.000722	CcSEcCtD
Midodrine—Pruritus—Niacin—coronary artery disease	0.000158	0.000721	CcSEcCtD
Midodrine—Asthenia—Pravastatin—coronary artery disease	0.000157	0.00072	CcSEcCtD
Midodrine—Gastrointestinal pain—Furosemide—coronary artery disease	0.000157	0.000719	CcSEcCtD
Midodrine—Rash—Eplerenone—coronary artery disease	0.000157	0.000719	CcSEcCtD
Midodrine—Dermatitis—Eplerenone—coronary artery disease	0.000157	0.000718	CcSEcCtD
Midodrine—Confusional state—Timolol—coronary artery disease	0.000157	0.000717	CcSEcCtD
Midodrine—Abdominal pain—Perindopril—coronary artery disease	0.000156	0.000715	CcSEcCtD
Midodrine—Headache—Eplerenone—coronary artery disease	0.000156	0.000714	CcSEcCtD
Midodrine—Nervous system disorder—Ramipril—coronary artery disease	0.000156	0.000713	CcSEcCtD
Midodrine—Pruritus—Pravastatin—coronary artery disease	0.000155	0.00071	CcSEcCtD
Midodrine—Nausea—Clopidogrel—coronary artery disease	0.000155	0.00071	CcSEcCtD
Midodrine—Tachycardia—Ramipril—coronary artery disease	0.000155	0.00071	CcSEcCtD
Midodrine—Skin disorder—Ramipril—coronary artery disease	0.000154	0.000706	CcSEcCtD
Midodrine—Nausea—Lovastatin—coronary artery disease	0.000154	0.000705	CcSEcCtD
Midodrine—Rash—Simvastatin—coronary artery disease	0.000153	0.0007	CcSEcCtD
Midodrine—Dermatitis—Simvastatin—coronary artery disease	0.000153	0.0007	CcSEcCtD
Midodrine—Asthenia—Trandolapril—coronary artery disease	0.000153	0.0007	CcSEcCtD
Midodrine—Feeling abnormal—Losartan—coronary artery disease	0.000153	0.000699	CcSEcCtD
Midodrine—Nervous system disorder—Timolol—coronary artery disease	0.000152	0.000697	CcSEcCtD
Midodrine—Asthenia—Enalapril—coronary artery disease	0.000152	0.000697	CcSEcCtD
Midodrine—Headache—Simvastatin—coronary artery disease	0.000152	0.000696	CcSEcCtD
Midodrine—Abdominal pain—Furosemide—coronary artery disease	0.000152	0.000695	CcSEcCtD
Midodrine—Gastrointestinal pain—Losartan—coronary artery disease	0.000151	0.000694	CcSEcCtD
Midodrine—Dizziness—Valsartan—coronary artery disease	0.000151	0.000694	CcSEcCtD
Midodrine—Nausea—Ezetimibe—coronary artery disease	0.000151	0.000692	CcSEcCtD
Midodrine—Skin disorder—Timolol—coronary artery disease	0.000151	0.000691	CcSEcCtD
Midodrine—Dizziness—Olmesartan—coronary artery disease	0.000151	0.00069	CcSEcCtD
Midodrine—Pruritus—Trandolapril—coronary artery disease	0.000151	0.00069	CcSEcCtD
Midodrine—Asthenia—Telmisartan—coronary artery disease	0.00015	0.000687	CcSEcCtD
Midodrine—Pruritus—Enalapril—coronary artery disease	0.00015	0.000687	CcSEcCtD
Midodrine—Anxiety—Lisinopril—coronary artery disease	0.00015	0.000686	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000149	0.000683	CcSEcCtD
Midodrine—Pruritus—Telmisartan—coronary artery disease	0.000148	0.000678	CcSEcCtD
Midodrine—Nausea—Eplerenone—coronary artery disease	0.000148	0.000677	CcSEcCtD
Midodrine—Dizziness—Niacin—coronary artery disease	0.000147	0.000674	CcSEcCtD
Midodrine—Dry mouth—Lisinopril—coronary artery disease	0.000147	0.000673	CcSEcCtD
Midodrine—Abdominal pain—Losartan—coronary artery disease	0.000146	0.000671	CcSEcCtD
Midodrine—Asthenia—Captopril—coronary artery disease	0.000146	0.000668	CcSEcCtD
Midodrine—Confusional state—Lisinopril—coronary artery disease	0.000145	0.000665	CcSEcCtD
Midodrine—Dizziness—Pravastatin—coronary artery disease	0.000145	0.000664	CcSEcCtD
Midodrine—Rash—Valsartan—coronary artery disease	0.000144	0.000661	CcSEcCtD
Midodrine—Dermatitis—Valsartan—coronary artery disease	0.000144	0.000661	CcSEcCtD
Midodrine—Nausea—Simvastatin—coronary artery disease	0.000144	0.00066	CcSEcCtD
Midodrine—Pruritus—Captopril—coronary artery disease	0.000144	0.000659	CcSEcCtD
Midodrine—Rash—Olmesartan—coronary artery disease	0.000144	0.000658	CcSEcCtD
Midodrine—Insomnia—Ramipril—coronary artery disease	0.000144	0.000658	CcSEcCtD
Midodrine—Dermatitis—Olmesartan—coronary artery disease	0.000144	0.000657	CcSEcCtD
Midodrine—Headache—Valsartan—coronary artery disease	0.000143	0.000657	CcSEcCtD
Midodrine—Headache—Olmesartan—coronary artery disease	0.000143	0.000654	CcSEcCtD
Midodrine—Paraesthesia—Ramipril—coronary artery disease	0.000143	0.000653	CcSEcCtD
Midodrine—Asthenia—Perindopril—coronary artery disease	0.000142	0.000649	CcSEcCtD
Midodrine—Dyspnoea—Ramipril—coronary artery disease	0.000142	0.000648	CcSEcCtD
Midodrine—Somnolence—Ramipril—coronary artery disease	0.000141	0.000647	CcSEcCtD
Midodrine—Dizziness—Trandolapril—coronary artery disease	0.000141	0.000645	CcSEcCtD
Midodrine—Tachycardia—Lisinopril—coronary artery disease	0.000141	0.000644	CcSEcCtD
Midodrine—Insomnia—Timolol—coronary artery disease	0.00014	0.000643	CcSEcCtD
Midodrine—Rash—Niacin—coronary artery disease	0.00014	0.000643	CcSEcCtD
Midodrine—Dermatitis—Niacin—coronary artery disease	0.00014	0.000642	CcSEcCtD
Midodrine—Dizziness—Enalapril—coronary artery disease	0.00014	0.000642	CcSEcCtD
Midodrine—Skin disorder—Lisinopril—coronary artery disease	0.00014	0.000641	CcSEcCtD
Midodrine—Dyspepsia—Ramipril—coronary artery disease	0.00014	0.00064	CcSEcCtD
Midodrine—Pruritus—Perindopril—coronary artery disease	0.00014	0.00064	CcSEcCtD
Midodrine—Headache—Niacin—coronary artery disease	0.000139	0.000639	CcSEcCtD
Midodrine—Paraesthesia—Timolol—coronary artery disease	0.000139	0.000638	CcSEcCtD
Midodrine—Dyspnoea—Timolol—coronary artery disease	0.000138	0.000634	CcSEcCtD
Midodrine—Dizziness—Telmisartan—coronary artery disease	0.000138	0.000633	CcSEcCtD
Midodrine—Rash—Pravastatin—coronary artery disease	0.000138	0.000633	CcSEcCtD
Midodrine—Dermatitis—Pravastatin—coronary artery disease	0.000138	0.000632	CcSEcCtD
Midodrine—Somnolence—Timolol—coronary artery disease	0.000138	0.000632	CcSEcCtD
Midodrine—Asthenia—Furosemide—coronary artery disease	0.000138	0.000631	CcSEcCtD
Midodrine—Headache—Pravastatin—coronary artery disease	0.000137	0.000629	CcSEcCtD
Midodrine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000137	0.000628	CcSEcCtD
Midodrine—Dyspepsia—Timolol—coronary artery disease	0.000137	0.000626	CcSEcCtD
Midodrine—Nausea—Valsartan—coronary artery disease	0.000136	0.000623	CcSEcCtD
Midodrine—Pruritus—Furosemide—coronary artery disease	0.000136	0.000622	CcSEcCtD
Midodrine—Nausea—Olmesartan—coronary artery disease	0.000135	0.00062	CcSEcCtD
Midodrine—Dizziness—Captopril—coronary artery disease	0.000134	0.000616	CcSEcCtD
Midodrine—Rash—Trandolapril—coronary artery disease	0.000134	0.000615	CcSEcCtD
Midodrine—Dermatitis—Trandolapril—coronary artery disease	0.000134	0.000614	CcSEcCtD
Midodrine—Gastrointestinal disorder—Timolol—coronary artery disease	0.000134	0.000614	CcSEcCtD
Midodrine—Rash—Enalapril—coronary artery disease	0.000134	0.000612	CcSEcCtD
Midodrine—Dermatitis—Enalapril—coronary artery disease	0.000134	0.000612	CcSEcCtD
Midodrine—Headache—Trandolapril—coronary artery disease	0.000133	0.000611	CcSEcCtD
Midodrine—Asthenia—Losartan—coronary artery disease	0.000133	0.000609	CcSEcCtD
Midodrine—Headache—Enalapril—coronary artery disease	0.000133	0.000608	CcSEcCtD
Midodrine—Pain—Timolol—coronary artery disease	0.000133	0.000608	CcSEcCtD
Midodrine—Nausea—Niacin—coronary artery disease	0.000132	0.000606	CcSEcCtD
Midodrine—Rash—Telmisartan—coronary artery disease	0.000132	0.000604	CcSEcCtD
Midodrine—Dermatitis—Telmisartan—coronary artery disease	0.000132	0.000603	CcSEcCtD
Midodrine—Pruritus—Losartan—coronary artery disease	0.000131	0.0006	CcSEcCtD
Midodrine—Headache—Telmisartan—coronary artery disease	0.000131	0.0006	CcSEcCtD
Midodrine—Feeling abnormal—Ramipril—coronary artery disease	0.000131	0.000599	CcSEcCtD
Midodrine—Dizziness—Perindopril—coronary artery disease	0.000131	0.000598	CcSEcCtD
Midodrine—Insomnia—Lisinopril—coronary artery disease	0.00013	0.000597	CcSEcCtD
Midodrine—Nausea—Pravastatin—coronary artery disease	0.00013	0.000596	CcSEcCtD
Midodrine—Gastrointestinal pain—Ramipril—coronary artery disease	0.00013	0.000595	CcSEcCtD
Midodrine—Paraesthesia—Lisinopril—coronary artery disease	0.000129	0.000592	CcSEcCtD
Midodrine—Dyspnoea—Lisinopril—coronary artery disease	0.000128	0.000588	CcSEcCtD
Midodrine—Rash—Captopril—coronary artery disease	0.000128	0.000587	CcSEcCtD
Midodrine—Dermatitis—Captopril—coronary artery disease	0.000128	0.000587	CcSEcCtD
Midodrine—Somnolence—Lisinopril—coronary artery disease	0.000128	0.000586	CcSEcCtD
Midodrine—Feeling abnormal—Timolol—coronary artery disease	0.000128	0.000586	CcSEcCtD
Midodrine—Headache—Captopril—coronary artery disease	0.000127	0.000583	CcSEcCtD
Midodrine—Gastrointestinal pain—Timolol—coronary artery disease	0.000127	0.000581	CcSEcCtD
Midodrine—Dizziness—Furosemide—coronary artery disease	0.000127	0.000581	CcSEcCtD
Midodrine—Dyspepsia—Lisinopril—coronary artery disease	0.000127	0.000581	CcSEcCtD
Midodrine—Nausea—Trandolapril—coronary artery disease	0.000126	0.000579	CcSEcCtD
Midodrine—Nausea—Enalapril—coronary artery disease	0.000126	0.000577	CcSEcCtD
Midodrine—Abdominal pain—Ramipril—coronary artery disease	0.000126	0.000575	CcSEcCtD
Midodrine—Rash—Perindopril—coronary artery disease	0.000124	0.00057	CcSEcCtD
Midodrine—Dermatitis—Perindopril—coronary artery disease	0.000124	0.00057	CcSEcCtD
Midodrine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000124	0.000569	CcSEcCtD
Midodrine—Nausea—Telmisartan—coronary artery disease	0.000124	0.000569	CcSEcCtD
Midodrine—Headache—Perindopril—coronary artery disease	0.000124	0.000567	CcSEcCtD
Midodrine—Pain—Lisinopril—coronary artery disease	0.000123	0.000564	CcSEcCtD
Midodrine—Abdominal pain—Timolol—coronary artery disease	0.000123	0.000562	CcSEcCtD
Midodrine—Dizziness—Losartan—coronary artery disease	0.000122	0.000561	CcSEcCtD
Midodrine—Rash—Furosemide—coronary artery disease	0.000121	0.000554	CcSEcCtD
Midodrine—Dermatitis—Furosemide—coronary artery disease	0.000121	0.000554	CcSEcCtD
Midodrine—Nausea—Captopril—coronary artery disease	0.000121	0.000553	CcSEcCtD
Midodrine—Headache—Furosemide—coronary artery disease	0.00012	0.000551	CcSEcCtD
Midodrine—Feeling abnormal—Lisinopril—coronary artery disease	0.000119	0.000544	CcSEcCtD
Midodrine—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000118	0.000539	CcSEcCtD
Midodrine—Nausea—Perindopril—coronary artery disease	0.000117	0.000537	CcSEcCtD
Midodrine—Rash—Losartan—coronary artery disease	0.000117	0.000535	CcSEcCtD
Midodrine—Dermatitis—Losartan—coronary artery disease	0.000117	0.000534	CcSEcCtD
Midodrine—Headache—Losartan—coronary artery disease	0.000116	0.000531	CcSEcCtD
Midodrine—Nausea—Furosemide—coronary artery disease	0.000114	0.000522	CcSEcCtD
Midodrine—Asthenia—Ramipril—coronary artery disease	0.000114	0.000522	CcSEcCtD
Midodrine—Abdominal pain—Lisinopril—coronary artery disease	0.000114	0.000521	CcSEcCtD
Midodrine—Pruritus—Ramipril—coronary artery disease	0.000112	0.000515	CcSEcCtD
Midodrine—Asthenia—Timolol—coronary artery disease	0.000111	0.00051	CcSEcCtD
Midodrine—Nausea—Losartan—coronary artery disease	0.00011	0.000504	CcSEcCtD
Midodrine—Pruritus—Timolol—coronary artery disease	0.00011	0.000503	CcSEcCtD
Midodrine—Dizziness—Ramipril—coronary artery disease	0.000105	0.000481	CcSEcCtD
Midodrine—Asthenia—Lisinopril—coronary artery disease	0.000103	0.000473	CcSEcCtD
Midodrine—Dizziness—Timolol—coronary artery disease	0.000103	0.00047	CcSEcCtD
Midodrine—Pruritus—Lisinopril—coronary artery disease	0.000102	0.000467	CcSEcCtD
Midodrine—Rash—Ramipril—coronary artery disease	0.0001	0.000459	CcSEcCtD
Midodrine—Dermatitis—Ramipril—coronary artery disease	0.0001	0.000458	CcSEcCtD
Midodrine—Headache—Ramipril—coronary artery disease	9.95e-05	0.000456	CcSEcCtD
Midodrine—Rash—Timolol—coronary artery disease	9.79e-05	0.000448	CcSEcCtD
Midodrine—Dermatitis—Timolol—coronary artery disease	9.78e-05	0.000448	CcSEcCtD
Midodrine—Headache—Timolol—coronary artery disease	9.72e-05	0.000445	CcSEcCtD
Midodrine—Dizziness—Lisinopril—coronary artery disease	9.52e-05	0.000436	CcSEcCtD
Midodrine—Nausea—Ramipril—coronary artery disease	9.43e-05	0.000432	CcSEcCtD
Midodrine—Nausea—Timolol—coronary artery disease	9.22e-05	0.000422	CcSEcCtD
Midodrine—Rash—Lisinopril—coronary artery disease	9.08e-05	0.000416	CcSEcCtD
Midodrine—Dermatitis—Lisinopril—coronary artery disease	9.07e-05	0.000415	CcSEcCtD
Midodrine—Headache—Lisinopril—coronary artery disease	9.02e-05	0.000413	CcSEcCtD
Midodrine—Nausea—Lisinopril—coronary artery disease	8.55e-05	0.000392	CcSEcCtD
Midodrine—ADRA1B—Signaling Pathways—KNG1—coronary artery disease	1.07e-05	0.000113	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CREB1—coronary artery disease	1.07e-05	0.000113	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—POMC—coronary artery disease	1.07e-05	0.000113	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGTR1—coronary artery disease	1.07e-05	0.000113	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGF1—coronary artery disease	1.06e-05	0.000112	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CSF2—coronary artery disease	1.06e-05	0.000112	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LPL—coronary artery disease	1.06e-05	0.000112	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MEF2C—coronary artery disease	1.05e-05	0.000111	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RPS6KB1—coronary artery disease	1.05e-05	0.000111	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—BDKRB2—coronary artery disease	1.05e-05	0.000111	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL12—coronary artery disease	1.05e-05	0.000111	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL2—coronary artery disease	1.05e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—POMC—coronary artery disease	1.05e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6R—coronary artery disease	1.04e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—F2—coronary artery disease	1.04e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL10—coronary artery disease	1.04e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PLG—coronary artery disease	1.04e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6ST—coronary artery disease	1.04e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JUNB—coronary artery disease	1.03e-05	0.000108	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLCB1—coronary artery disease	1.02e-05	0.000108	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ITGB3—coronary artery disease	1.02e-05	0.000108	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—VCAN—coronary artery disease	1.01e-05	0.000107	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRB2—coronary artery disease	1.01e-05	0.000107	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALDOA—coronary artery disease	1e-05	0.000106	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR7—coronary artery disease	1e-05	0.000106	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCE—coronary artery disease	9.98e-06	0.000105	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—JAK2—coronary artery disease	9.97e-06	0.000105	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCL8—coronary artery disease	9.96e-06	0.000105	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SOCS1—coronary artery disease	9.96e-06	0.000105	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—S100B—coronary artery disease	9.93e-06	0.000105	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PPP2CA—coronary artery disease	9.91e-06	0.000105	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SOCS3—coronary artery disease	9.83e-06	0.000104	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—DCN—coronary artery disease	9.74e-06	0.000103	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRKCD—coronary artery disease	9.73e-06	0.000103	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—KITLG—coronary artery disease	9.72e-06	0.000103	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFBR2—coronary artery disease	9.72e-06	0.000103	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ITGAV—coronary artery disease	9.55e-06	0.000101	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR2A—coronary artery disease	9.52e-06	0.000101	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KNG1—coronary artery disease	9.52e-06	0.000101	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—C3—coronary artery disease	9.51e-06	0.0001	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—STAT5A—coronary artery disease	9.5e-06	0.0001	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP3—coronary artery disease	9.5e-06	0.0001	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—POMC—coronary artery disease	9.49e-06	0.0001	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CREB1—coronary artery disease	9.49e-06	0.0001	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALDH2—coronary artery disease	9.48e-06	0.0001	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGTR1—coronary artery disease	9.47e-06	0.0001	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL2—coronary artery disease	9.29e-06	9.81e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6R—coronary artery disease	9.26e-06	9.78e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL10—coronary artery disease	9.25e-06	9.77e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LIPC—coronary artery disease	9.24e-06	9.76e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HBA1—coronary artery disease	9.24e-06	9.76e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	9.24e-06	9.76e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	9.24e-06	9.76e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLG—coronary artery disease	9.22e-06	9.74e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOC3—coronary artery disease	9.18e-06	9.7e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOB—coronary artery disease	9.18e-06	9.69e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LDLR—coronary artery disease	9.12e-06	9.64e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCL8—coronary artery disease	9.1e-06	9.61e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HIF1A—coronary artery disease	9.07e-06	9.58e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—JAK2—coronary artery disease	9.06e-06	9.56e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AGT—coronary artery disease	9.03e-06	9.54e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EDN1—coronary artery disease	9.03e-06	9.54e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	9.02e-06	9.52e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTT1—coronary artery disease	9.02e-06	9.52e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB2—coronary artery disease	8.98e-06	9.48e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL5—coronary artery disease	8.96e-06	9.47e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCLC—coronary artery disease	8.91e-06	9.41e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CETP—coronary artery disease	8.91e-06	9.41e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCE—coronary artery disease	8.87e-06	9.36e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—JAK2—coronary artery disease	8.86e-06	9.35e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LEP—coronary artery disease	8.85e-06	9.35e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOE—coronary artery disease	8.85e-06	9.35e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SOCS1—coronary artery disease	8.84e-06	9.34e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CSF2—coronary artery disease	8.83e-06	9.32e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGF1—coronary artery disease	8.83e-06	9.32e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—S100B—coronary artery disease	8.82e-06	9.32e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SDC1—coronary artery disease	8.81e-06	9.31e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LPL—coronary artery disease	8.77e-06	9.26e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOA1—coronary artery disease	8.75e-06	9.24e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SOCS3—coronary artery disease	8.74e-06	9.22e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MEF2C—coronary artery disease	8.69e-06	9.17e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RPS6KB1—coronary artery disease	8.69e-06	9.17e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—KDR—coronary artery disease	8.67e-06	9.16e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KITLG—coronary artery disease	8.63e-06	9.12e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFBR2—coronary artery disease	8.63e-06	9.12e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK14—coronary artery disease	8.62e-06	9.1e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ITGB3—coronary artery disease	8.47e-06	8.94e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ESR1—coronary artery disease	8.45e-06	8.93e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP3—coronary artery disease	8.44e-06	8.91e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—STAT5A—coronary artery disease	8.44e-06	8.91e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—F2—coronary artery disease	8.35e-06	8.82e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FN1—coronary artery disease	8.35e-06	8.82e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PSMB5—coronary artery disease	8.33e-06	8.79e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PSMA6—coronary artery disease	8.33e-06	8.79e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6ST—coronary artery disease	8.31e-06	8.78e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCL8—coronary artery disease	8.27e-06	8.73e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NFKBIA—coronary artery disease	8.25e-06	8.71e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PPP2CA—coronary artery disease	8.22e-06	8.69e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOB—coronary artery disease	8.15e-06	8.61e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CTGF—coronary artery disease	8.13e-06	8.59e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCL8—coronary artery disease	8.08e-06	8.54e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCD—coronary artery disease	8.08e-06	8.53e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMGCR—coronary artery disease	8.06e-06	8.51e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GOT2—coronary artery disease	8.06e-06	8.51e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—JAK2—coronary artery disease	8.04e-06	8.49e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EDN1—coronary artery disease	8.02e-06	8.47e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—KIT—coronary artery disease	7.99e-06	8.44e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL5—coronary artery disease	7.96e-06	8.41e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR2A—coronary artery disease	7.9e-06	8.35e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—C3—coronary artery disease	7.89e-06	8.33e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CSF2—coronary artery disease	7.84e-06	8.28e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGF1—coronary artery disease	7.84e-06	8.28e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LPL—coronary artery disease	7.79e-06	8.22e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RPS6KB1—coronary artery disease	7.72e-06	8.15e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MEF2C—coronary artery disease	7.72e-06	8.15e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GSK3B—coronary artery disease	7.67e-06	8.1e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—POMC—coronary artery disease	7.6e-06	8.03e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CREB1—coronary artery disease	7.6e-06	8.03e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	7.53e-06	7.95e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ITGB3—coronary artery disease	7.52e-06	7.94e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AGT—coronary artery disease	7.5e-06	7.92e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL2—coronary artery disease	7.44e-06	7.86e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6R—coronary artery disease	7.42e-06	7.83e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PLCB1—coronary artery disease	7.41e-06	7.83e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LEP—coronary artery disease	7.35e-06	7.76e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOE—coronary artery disease	7.35e-06	7.76e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCL8—coronary artery disease	7.34e-06	7.75e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1—coronary artery disease	7.31e-06	7.72e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PPP2CA—coronary artery disease	7.3e-06	7.71e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—MAPK1—coronary artery disease	7.28e-06	7.69e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	7.26e-06	7.67e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—KDR—coronary artery disease	7.2e-06	7.6e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ABCA1—coronary artery disease	7.18e-06	7.59e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCD—coronary artery disease	7.17e-06	7.58e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	7.15e-06	7.55e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR2A—coronary artery disease	7.02e-06	7.41e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	7.01e-06	7.41e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—C3—coronary artery disease	7.01e-06	7.4e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GGT1—coronary artery disease	6.96e-06	7.35e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GOT1—coronary artery disease	6.96e-06	7.35e-05	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PIK3CA—coronary artery disease	6.96e-06	7.35e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SERPINE1—coronary artery disease	6.95e-06	7.34e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—F2—coronary artery disease	6.93e-06	7.32e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FN1—coronary artery disease	6.93e-06	7.32e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	6.9e-06	7.29e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	6.85e-06	7.23e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	6.72e-06	7.1e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	6.69e-06	7.06e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AGT—coronary artery disease	6.66e-06	7.03e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	6.63e-06	7e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—KIT—coronary artery disease	6.63e-06	7e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LEP—coronary artery disease	6.53e-06	6.89e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOE—coronary artery disease	6.53e-06	6.89e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	6.45e-06	6.81e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	6.45e-06	6.81e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KDR—coronary artery disease	6.39e-06	6.75e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	6.36e-06	6.72e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	6.35e-06	6.71e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	6.32e-06	6.67e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—POMC—coronary artery disease	6.31e-06	6.67e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	6.31e-06	6.67e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTP1—coronary artery disease	6.25e-06	6.6e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	6.23e-06	6.58e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	6.19e-06	6.54e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	6.18e-06	6.52e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMOX1—coronary artery disease	6.16e-06	6.51e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	6.16e-06	6.5e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—F2—coronary artery disease	6.15e-06	6.5e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FN1—coronary artery disease	6.15e-06	6.5e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	6.13e-06	6.47e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CAT—coronary artery disease	6.08e-06	6.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	6.08e-06	6.42e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	6.07e-06	6.41e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	6.04e-06	6.38e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOB—coronary artery disease	5.9e-06	6.24e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KIT—coronary artery disease	5.89e-06	6.22e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	5.88e-06	6.21e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	5.77e-06	6.1e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	5.77e-06	6.09e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTM1—coronary artery disease	5.74e-06	6.07e-05	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	5.68e-06	6e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	5.65e-06	5.97e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LPL—coronary artery disease	5.64e-06	5.95e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	5.63e-06	5.95e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—POMC—coronary artery disease	5.61e-06	5.92e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	5.61e-06	5.92e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	5.59e-06	5.91e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	5.58e-06	5.89e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	5.5e-06	5.81e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GPX1—coronary artery disease	5.5e-06	5.81e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	5.49e-06	5.79e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	5.48e-06	5.79e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	5.47e-06	5.78e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	5.39e-06	5.7e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	5.37e-06	5.67e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CD36—coronary artery disease	5.36e-06	5.66e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	5.35e-06	5.65e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	5.32e-06	5.62e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	5.29e-06	5.59e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	5.24e-06	5.54e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	5.16e-06	5.45e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	5.13e-06	5.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	5.12e-06	5.41e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MTHFR—coronary artery disease	5.08e-06	5.36e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	4.96e-06	5.24e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	4.89e-06	5.16e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	4.88e-06	5.16e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AGT—coronary artery disease	4.82e-06	5.09e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	4.78e-06	5.05e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	4.75e-06	5.02e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOE—coronary artery disease	4.73e-06	4.99e-05	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	4.72e-06	4.98e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	4.67e-06	4.94e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOA1—coronary artery disease	4.67e-06	4.93e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	4.66e-06	4.92e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	4.64e-06	4.9e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	4.55e-06	4.8e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	4.42e-06	4.66e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	4.39e-06	4.63e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	4.34e-06	4.58e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	4.3e-06	4.54e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	4.28e-06	4.52e-05	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	4.19e-06	4.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	4.15e-06	4.38e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	4.12e-06	4.36e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARG—coronary artery disease	4.12e-06	4.35e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—POMC—coronary artery disease	4.06e-06	4.29e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	4.04e-06	4.27e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	3.97e-06	4.19e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	3.92e-06	4.14e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	3.8e-06	4.02e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	3.73e-06	3.94e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—coronary artery disease	3.7e-06	3.91e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	3.64e-06	3.84e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	3.57e-06	3.77e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NOS3—coronary artery disease	3.54e-06	3.74e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	3.52e-06	3.72e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—coronary artery disease	3.3e-06	3.49e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.24e-06	3.42e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	3.23e-06	3.41e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	3.17e-06	3.35e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	3.1e-06	3.27e-05	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	3.05e-06	3.22e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	2.75e-06	2.91e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	2.74e-06	2.9e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	2.53e-06	2.67e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	2.44e-06	2.57e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	2.25e-06	2.37e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.99e-06	2.1e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.63e-06	1.72e-05	CbGpPWpGaD
